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Single nucleotide variations (SNVs) at 5 loci (17564,
21721, 22222, 23823, and 27827) were used to define the
molecular epidemiologic characteristics of severe acute
respiratory syndrome–associated coronavirus (SARS-CoV)
from Beijing patients. Five fragments targeted at the SNV
loci were amplified directly from clinical samples by using
reverse transcription–polymerase chain reaction (RT-
PCR), before sequencing the amplified products. Analyses
of 45 sequences obtained from 29 patients showed that the
GGCTC motif dominated among samples collected from
March to early April 2003; the TGTTT motif predominanted
afterwards. The switch from GGCTC to TGTTT was
observed among patients belonging to the same cluster,
which ruled out the possibility of the coincidental superpo-
sition of 2 epidemics running in parallel in Beijing. The
Beijing isolates underwent the same change pattern report-
ed from Guangdong Province. The same series of muta-
tions occurring in separate geographic locations and at
different times suggests a dominant process of viral adap-
tation to the host.
S
evere acute respiratory syndrome (SARS) is a new
infectious disease that spread worldwide in early 2003,
affecting >30 countries, with >8,098 cases and 774 deaths
reported (1). Beijing, People’s Republic of China, experi-
enced the largest SARS outbreak in the world, with 2,523
cases and 181 deaths by June 12, 2003 (2,3). The epidem-
ic occurred in 2 phases. The first phase began on March 5,
2003, and was caused by a patient who had been infected
in Guangzhou and was involved in a superspreader event
(SSE) in Beijing hospitals. Most patients in this period
proved to be directly or indirectly linked with the index
patient by traditional epidemiologic investigations.
Molecular epidemiology, based on genome sequencing of
the early isolates, also provided evidence that Beijing
infections were closely related to those from the
Guangdong epidemic (4). The second phase was marked
by widespread transmission in healthcare facilities and
communities, with incidence peaking in late April, fol-
lowed by a dramatic decline in occurrence during the first
week of May. The last probable case was noted on May 29,
2003 (5). During this phase, many case-patients had no
apparent contact with SARS patients.
After the sequencing of the whole genome (6–9) infor-
mation on viral strains from different geographic and tem-
poral origins became available in GenBank. Comparative
sequence analyses identified 5 loci, sequence variants of
which segregated together as specific genotypic patterns,
which could be used to define epidemic phases (10). All or
some of the 5 loci were included in previous molecular
epidemiologic studies (4,11–13), making them important
genetic signatures to differentiate lineage-specific and
temporal-specific patterns. In this study, we investigated
the genetic variations of SARS-CoV in Beijing based on
the 5-locus signature. Also, by sequence comparison
among patients from 1 case cluster and different samples
from 1 patient, the adaptable mutation of the virus in the
host was further explored.
Methods
Participants
Study participants were recruited from 2 hospitals des-
ignated for SARS patients in Beijing. All of them fit the
World Health Organization (WHO) case definition for
probable SARS, i.e., temperature >38ºC, cough or short-
ness of breath, new pulmonary infiltrates on chest radi-
ograph, and a history of exposure to a SARS patient or of
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After informed consent was obtained, epidemiologic and
clinical data were collected from the participants by using
a standard data collection form with interview and medical
record review. The information obtained included the fol-
lowing items: age, sex, occupation, medical history, time
and nature of exposure, symptoms and physical findings,
laboratory tests at admission to hospital, and outcomes on
discharge or transfer. Patients also provided clinical speci-
mens (sputum and stool) for SARS-CoV detection by RT-
PCR assay with specific primers (COR1, COR2)
recommended by WHO. Only the patients with positive
RT-PCR results were included in the study.
Laboratory Methods 
Specimens were analyzed by using RT-PCR tech-
niques. Briefly, total RNA was extracted by using the
QIAamp virus RNA mini kit (Qiagen, Hilden, Germany)
as instructed by the manufacturer. RNA was used to syn-
thesize cDNA with the SuperScript II RNase H– reverse
transcriptase system (Invitrogen, Carlsbad, CA, USA).
Five sets of primers were used in nested PCR to amplify
the fragments covering the 5-locus genetic signatures
(17564,21721, 22222, 23823, and 27827) (Table 1). Then,
with the purified PCR products as templates and the sec-
ond round primers as sequencing primers, the fragments
were sequenced in ABI Prism 377 DNA sequencer
(Applied Biosystems Inc, Foster City, CA, USA). Each
PCR fragment was directly sequenced from both inward
and outward directions, in duplicate.
All the original base data were processed for base call-
ing, assembly, and editing by the SegMan II sequences
analysis software of DNA Star package (DNASTAR,
Madison, WI, USA). The comparisons with other
sequences available from public database (GenBank) were
made by using the default parameter of ClustalW
(http://www.ebi.ac.uk/clustalw/). Single nucleotide varia-
tions (SNVs) were indicated, and the deduced amino acid
changes were described. 
Results
A total of 160 samples (81 stools and 79 sputum sam-
ples) from 62 patients with positive results by RT-PCR
were included this study. Of these, 45 samples (36 sputum
samples and 9 stools) from 29 patients (17 men and 12
women, with a median age of 32 years) yielded amplicons
for the 5 targeted loci (Table 2). The patients came from 2
SARS-designated hospitals in Beijing, with disease onset
ranging from March to May, 2003. Four patients had seri-
ous conditions during hospitalization, including pul-
monary aggravation requiring oxygen ventilation or
transfer to an intensive care unit. No patient died.
The sequences of the 45 positive specimens were com-
pared with SARS-CoV genome sequences available from
the public database (GenBank). The sequence variants in 5
loci (17564, 21721, 22222, 23823, and 27827) defined 3
kinds of motifs: GGCTC, TGTTT, and GATTC (Table 2).
In addition, 4 new SNVs were identified at nucleotides
17620, 22077, 22589, and 27749 in >1 patient. These vari-
ations appeared independently in several isolates, which
indicates that they are not RT-PCR artifacts. None of them
had been previously reported, with 3 nucleotide substitu-
tions leading to amino acid changes (Table 3). 
Twelve patients in this study belonged to a cluster. They
derived from an SSE indirectly linked with the earliest
SARS patients in Beijing. The first 2 patients of this clus-
ter, who became ill on March 10 and 21, respectively, har-
bored the GGCTC motif. The remaining patients, who
became ill from March 31 to May 4, showed the TGTTT
motif. Among patients outside of the cluster, 5 of 6 patients
with onset date before April had the GGCTC motif, while
the TGTTT motif became predominant later (9 of 11
patients until May 12). Anew motif, GATTC, was found in
2 patients outside the cluster. In addition, no intrapatient
variation was observed in the 5 amplicons from specimens
collected at different times or from different sources (spu-
tum or stools).
The possible role of genetic mutations in patients’prog-
nosis was also investigated. The presence of nucleotide
substitution was compared between 2 groups of patients: 1
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= 25) and 1 with adverse outcome (pulmonary aggravation
8–12 days after onset of symptoms requiring oxygen ven-
tilation or transfer to ICU; n = 4). No mutation was found
associated with disease severity (Table 2). 
Discussion
During the 2003 SARS epidemic, conventional epi-
demiologic investigation, aided by viral sequencing analy-
sis, identified viral genetic signatures that are linked to
geographic and temporal clusters of infection (4,10–12,
15–18). Findings of these studies are summarized in the
Figure, connecting the worldwide epidemic to a transmis-
sion event in hotel M in Hong Kong in late February 2003.
Beijing had experienced the SARS epidemic from
March to June; however, only a few Beijing strains from
the early epidemic have been analyzed in previous studies.
Our study is the first to provide phylogenetic information
on Beijing strains from the early and middle epidemic, as
well as the late epidemic, by using the 5-locus motif of pre-
vious studies. The series of mutations in the 5-locus motif
observed in Beijing followed the same path as isolates in
Guangdong Province and the worldwide epidemic, i.e., the
early introduction of GACTC motif was followed by tran-
sition to a GGCTC motif, before switching to a stable
TGTTT motif. The observation of the same series of muta-
tions occurring in 2 separate locations at different times
suggests a dominant process of viral adaptation to the host.
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SARS-CoV response to selection pressures in humans,
since early Beijing isolates (BJ01, BJ02, and BJ 03), which
are traceable to Guangdong, underwent an independent
selection process and would not be subject to the same
sampling bias caused by superspreading events in Hong
Kong isolates. The GGCTC→TGTTT switch was
observed among patients belonging to the same cluster in
this study, which rules out the possibility of the coinciden-
tal superposition of 2 epidemics (GGCTC and TGTTT)
coexisting in Beijing. 
The mutations involved in the GGCTC→TGTTT
switch are responsible for amino acid changes in a non-
structural protein (17564, region Orf1b) in S protein
(21721 and 22222) and in a noncoding region (27827, X3).
We were not able to identify a correlation between these
changes and the clinical status of patients. We did not find
sequence variations in specimens obtained from the same
patients either collected at different times or among differ-
ent specimen types, which suggests that within-individual
variations are rare in the partial genome of this study,
although the phenomenon was described in a previous
study (15). A new motif, GATTC, which represents a new
transitional motif between GACTC and TGTTT, was
described on 2 occasions in patients who were not part of
the cluster. Similarly, 4 new SNVs were identified at
nucleotides 17620, 22077, 22589, 27749.
In summary, this study confirms the evolution of
SARS-CoV strains towards a TGTTT motif in positions
17564, 21721, 22222, 23823, and 27827 in Beijing, as was
observed in Guangdong province before the hotel M out-
break in Hong Kong. Whether this motif is associated with
higher transmission or virulence remains to be elucidated.
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